FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 128 filers reported holding FIVE PRIME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,071,000 | – | 50,630 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 868,100 | $14,914,000,000 | 2.22% |
| EcoR1 Capital, LLC | 1,240,470 | $21,311,000 | 2.14% |
| Virtus ETF Advisers LLC | 36,128 | $621,000 | 0.54% |
| BB BIOTECH AG | 977,500 | $16,793,000 | 0.46% |
| Rock Springs Capital Management LP | 585,500 | $10,059,000 | 0.43% |
| Telemetry Investments, L.L.C. | 46,500 | $799,000 | 0.30% |
| Hilltop Holdings Inc. | 51,975 | $893,000 | 0.16% |
| A.R.T. Advisors, LLC | 158,769 | $2,727,000 | 0.11% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 71,552 | $1,229,000 | 0.09% |
| Eventide Asset Management | 105,000 | $1,804,000 | 0.08% |